ACMR
Acm Research Inc
83.40$
-0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.7% | +4.4% | +7.1% | +7.6% | +3.4% | +4.2% | +5.5% | +35.8% | +3.7% | +6.7% | +10.9% | |
| – | +5.4% | +4.5% | +9.3% | +7.6% | +2.6% | +4.3% | +6.3% | +43.3% | +3.3% | +7.5% | +9.8% | |
| – | -12.1% | +16.0% | +53.3% | +2.9% | +22.2% | +12.2% | -1.0% | +133.8% | -27.7% | +16.7% | +10.8% | |
| – | -6.8% | -2.0% | +33.2% | +0.9% | +18.7% | +11.0% | +2.5% | +123.7% | +3.4% | +10.2% | +13.5% | |
| – | +13.6% | +7.6% | +0.7% | +22.4% | +0.1% | -1.4% | +12.9% | +10.5% | +4.8% | +5.1% | +4.2% | |
| – | +7.5% | +6.6% | +3.7% | +4.3% | -4.9% | +1.9% | +6.4% | +4.3% | +3.9% | +5.0% | +6.1% | |
| – | -75.7% | +337.7% | -0.4% | +0.9% | -69.0% | -13.4% | -4.9% | -5.0% | +5.2% | -4.4% | -7.6% | |
| – | +6.1% | +5.5% | +11.8% | +8.8% | +4.8% | +2.4% | +8.9% | +4.4% | +6.4% | +4.3% | +1.2% | |
| – | +3.9% | +6.5% | +9.9% | +4.1% | +5.1% | -1.9% | +6.7% | +1.0% | +10.0% | 0.0% | +5.4% | |
| – | -6.0% | +56.4% | +20.0% | -12.8% | +18.8% | +21.4% | +23.3% | -17.7% | +16.5% | -1.6% | +36.4% | |
| – | +3.8% | -4.5% | +5.1% | +19.9% | -18.5% | -16.4% | +44.8% | +7.3% | +36.8% | -2.8% | +4.0% | |
| – | +35.7% | -1.0% | +32.6% | +49.7% | -0.5% | +27.5% | +21.1% | +18.6% | -7.5% | +23.4% | -12.7% | |
| – | +5.3% | +3.8% | +4.6% | +6.6% | +1.9% | +4.9% | +3.9% | +45.2% | +2.2% | +8.0% | +17.6% | |
| – | +3.0% | +11.1% | +13.9% | +15.6% | +13.4% | +7.8% | +10.6% | +11.6% | +1.3% | +4.9% | +24.2% | |
| – | +0.7% | +0.5% | +1.2% | -0.6% | -0.2% | +0.7% | +0.8% | +1.4% | +0.6% | +1.4% | +3.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.